Provenance du réseau au premier degré de Peter Elliott
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA.
55
| Subsidiary | Pharmaceuticals: Major | 55 |
CombinatoRx, Inc.
 CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA
14
| Extinct | Pharmaceuticals: Other | 14 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Peter Elliott via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Investor Relations Contact | |
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal Comptroller/Controller/Auditor | |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| REGENERON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Founder Corporate Officer/Principal Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| ARQULE, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
LeukoSite, Inc.
 LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology LeukoSite, Inc. develops drugs for treatment of cancer and inflammatory diseases. It produces drugs to block autoimmune and viral diseases associated with malfunctioning leukocytes or white blood cells. The company was founded in 1992 and is located in Cambridge, MA. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| CURIS, INC. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| MOMENTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal General Counsel Director/Board Member Corporate Officer/Principal | |
ActivBiotics, Inc.
 ActivBiotics, Inc. BiotechnologyHealth Technology ActivBiotics, Inc. discovers and develops pharmaceutical drugs. It provides discovery, development, and commercialization of therapies for the treatment of vascular disease, inflammation, and other high-value chronic and infectious diseases. The company was founded in 1996 and is headquartered in Lexington, MA. | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Founder Director/Board Member Director/Board Member | |
TARIS BioMedical LLC
 TARIS BioMedical LLC Pharmaceuticals: MajorHealth Technology TARIS BioMedical LLC operates as a clinical-stage pharmaceutical company. It specializes in urology, continuous local dosing, bladder diseases, oncology, voiding dysfunction. The company was founded by Robert S. Langer Jr., Christine Bunt, and Michael J. Cima in 2008 and is headquartered in Lexington, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Founder | |
Metamark Genetics, Inc.
 Metamark Genetics, Inc. Medical/Nursing ServicesHealth Services Metamark Genetics, Inc. provides molecular diagnostics services. It develops prognostic and predictive diagnostic tests that will enable personalized treatment planning for cancer patients. It transforms cancer diagnosis and treatment by developing pioneering diagnostic products based on its prognosis determinants platform. The company was founded by Kenneth E. Weg, Raju S. Kucherlapati, David Rimm, Lynda Chin and Ronald A. DePinho in November 2007 and is headquartered in Waltham, MA. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
| FORMA THERAPEUTICS HOLDINGS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
| University of Oxford | College/University | Doctorate Degree Doctorate Degree | |
| Boston University | College/University | Masters Business Admin Undergraduate Degree | |
Cambridge Discovery Chemistry
 Cambridge Discovery Chemistry Miscellaneous Commercial ServicesCommercial Services Part of Signature BioScience, Inc., Cambridge Discovery Chemistry provides chemistry research services. Cambridge Discovery Chemistry was acquired by Signature BioScience, Inc. from Millennium Pharmaceuticals, Inc. on July 16, 2001. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
DuPont Merck Pharmaceutical Co.
 DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member Chief Tech/Sci/R&D Officer | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Masters Business Admin Doctorate Degree Doctorate Degree Undergraduate Degree | |
| Rutgers State University of New Jersey | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree Corporate Officer/Principal | |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Masters Business Admin Masters Business Admin Undergraduate Degree Graduate Degree | |
| Princeton University | College/University | Undergraduate Degree Corporate Officer/Principal | |
| University of California, Berkeley | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| University of Massachusetts | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Worcester Polytechnic Institute | College/University | Graduate Degree Undergraduate Degree | |
| AVEO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Investor Relations Contact Chief Operating Officer | |
| Baylor College of Medicine | College/University | Doctorate Degree Doctorate Degree | |
Wyeth Research
 Wyeth Research Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Wyeth Research discovers and develops platforms encompassing pharmaceuticals. The company is based in Cambridge, MA. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| MOLECULAR PARTNERS AG | Biotechnology | Director/Board Member Director/Board Member | |
| EPIZYME, INC. | Biotechnology | Corporate Officer/Principal Director/Board Member | |
| Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| KARYOPHARM THERAPEUTICS INC. | Pharmaceuticals: Major | Director of Finance/CFO Founder Director of Finance/CFO | |
| VERASTEM, INC. | Biotechnology | Founder Chief Executive Officer Chairman Director of Finance/CFO | |
| SAGE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Chairman | |
| University of Pennsylvania Medical Center | College/University | Doctorate Degree Doctorate Degree | |
| DECIBEL THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Chief Executive Officer | |
| LEAP THERAPEUTICS, INC. | Biotechnology | Chairman Corporate Officer/Principal | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Founder Private Equity Investor |
Statistiques
Internationale
| Etats-Unis | 47 |
| Royaume-Uni | 2 |
| Israël | 2 |
| France | 2 |
| Suisse | 2 |
Sectorielle
| Health Technology | 33 |
| Consumer Services | 12 |
| Commercial Services | 4 |
| Finance | 3 |
| Health Services | 2 |
Opérationnelle
| Director/Board Member | 249 |
| Corporate Officer/Principal | 209 |
| Chief Tech/Sci/R&D Officer | 70 |
| Undergraduate Degree | 65 |
| Independent Dir/Board Member | 56 |
Relations les plus connectées
| Insiders | |
|---|---|
| Nicholas G. Galakatos | 38 |
| Norman Selby | 32 |
| Richard H. Aldrich | 31 |
| Chris Mirabelli | 29 |
| Steven Holtzman | 28 |
| Robert M. Forrester | 25 |
| Steven Gilman | 25 |
| Michael Kauffman | 24 |
| Julian Adams | 23 |
| Kevin Starr | 19 |
| Allan P. Marchington | 19 |
| Richard Pops | 17 |
| Nancy Simonian | 17 |
| Frank W. Haydu | 16 |
| Joe Bolen | 14 |
- Bourse
- Insiders
- Peter Elliott
- Connexions Sociétés
